2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

      1 , 1
      JAMA oncology

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepatocellular carcinoma (HCC) has the second-highest cancer-related mortality rate in the world because most patients are diagnosed at an intermediate to advanced stage when surgery is not suitable. Transcatheter arterial chemoembolization (TACE) is currently considered a first-line therapy for unresectable HCC. However, advancements in radiotherapy (RT) have resulted in some studies identifying a significant therapeutic benefit of TACE plus RT for unresectable HCC compared with TACE alone.

          Related collections

          Author and article information

          Journal
          JAMA Oncol
          JAMA oncology
          2374-2445
          2374-2437
          Sep 2015
          : 1
          : 6
          Affiliations
          [1 ] The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Sydney, Australia.
          Article
          2383146
          10.1001/jamaoncol.2015.2189
          26182200
          3eea2337-2730-47d7-a16d-bad75796f913
          History

          Comments

          Comment on this article